STUDY OF THE HEPATOPROTECTOR PROPERTIES OF THE DRUG TAUCIN
Keywords:
hepatotoxic effect, hepatoprotective effect, rats, paracetamol, zinc diaspartate, combination of taucineAbstract
This article presents an analysis of recent research by scientists who have used the hepatoprotective properties of the drug tausin in rat liver. Taurine has a moderate positive inotropic effect and promotes natriuresis and diuresis. Although recent studies have shown improvement in exercise tolerance in patients with taurine [17], it remains unknown whether taurine reduces risk in the general population. In addition, the question of reducing the mortality rate of patients with taurine has not been studied. There is reason to believe that taurine can increase the life expectancy of patients
References
Katzung B.G. Basic and clinical pharmacology T. 1. Moscow: "Binom", St. Petersburg: "Dialect"; 2008.
Mashkovsky M.D. Medicines. Moscow: New wave; 2005.
Acharya M. Comparison of the protective effects of N-acetylcysteine, hypotaurine and taurine against acetaminophen-induced hepatotoxicity in rats. J. Biomed. scientific 2010; 24:31–3.
Pashko A.Yu., Borisenok O.A., Bushma M.I. Taucine correction of metabolic disorders in the liver and organ function in rats with paracetamol intoxication. Toxicological Bulletin. 2015, pp. 42-45.
Rebrova O.Yu. Statistical analysis of medical data. Moscow: MediaSphere; 2002.
James L.P. [et al.] Pharmacokinetics of acetaminophen-protein adducts in adults with acetaminophen overdose and acute liver failure. Drag Metab Dispos. 2009; 37:1779-84.
Sheibak V.M., Sheibak L.N. The biological role of taurine in the body of mammals. Medical news. 2005; 10:65-15.
But-Gusaim L.St., Gerashchenko N.V., Bloshko T.E. Prospects for the use of zinc preparations in perinatology. Materials of the scientific-practical conference dedicated to 60 years of the ambulance service and 10 years of the GKO SMP. September 5-7, 2005. Grodno: GrGMU; 2005.
Truong-Tran A.K. other. The role of zinc in caspase activation and apoptotic cell death. Biometals. 2001; 14:315–330.
Schumann G. et al. IFCC Primary Reference Procedures for the Measurement of Enzyme Catalytic Activity Concentrations at 37°C. Part 3. Reference procedure for measuring the catalytic concentration of lactate dehydrogenase. wedge. chem. laboratory Med. 2002; 40:643-648.
Kamyshnikov V.S. Handbook of clinical and biochemical laboratory diagnostics T. 2. Minsk: "Belarus"; 2002.
Harada H. et al. Oral taurine prevents the development of ethanol-induced hypertension in rats. Hypertension res. 2000; 23:277–284.
Formigari A, Irato P, Santon A. Zinc, antioxidant systems and metallothionein in metal-mediated apoptosis: biochemical and cytochemical aspects. Comp. Biochem. Physiol. Fri. S. 2007; 146:443–459.
Pashko A.Yu., Bushma K.M., Borisenok O.A., Bushma M.I. Correction of hepatotoxicity indicators in plasma of rats with cholestasis with the drug "taucine". Toxicological Bulletin. 2015, pp. 12-15.
Shaffer S.V., Shimada-Takaura K., Jong S.J. Violation of the energy metabolism of taurine-deficient heart. Amino acids. 2016;48:549-558. D0I:10.1007/s00726-015-2110-2.
Azuma J, Sawamura A, Awata N. Benefits of taurine in chronic congestive heart failure. Jp Circ JP 95-99.
Ahmadian M, Roshan D, Ashurpor E. Taurine supplementation improves functional capacity, myocardial oxygen consumption, and electrical activity in heart failure. Appendix G diet. 2017;14:422-432. D0I: 10.1080/19390211.2016.1267059.
